The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: A longitudinal study
Abstract
An investigation has been undertaken to determine the effects of fenfluramine on glucose tolerance, insulin, fasting lipid and lipoprotein levels, in a series of twenty-five patients suffering from peripheral arterial disease. The results indicate that fenfluramine significantly improved glucose tolerance and that this was not the result of increased insulin production. Small but significant reduction in fasting cholesterol and β lipoprotein levels also occurred in most of the patients. Fenfluramine had no consistent effect on fasting nonesterified fatty acid, glycerides or pre-β lipoproteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,945
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
Kruman, I. I., Culmsee, C., Chan, S. L., Kruman, Y., Guo, Z., Penix, L., & Mattson, M. P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06920.2000 · Cited by 784
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717
Self-citation
Cited by
Sorted by citations
Tardy, A.-L., Pouteau, E., Marquez, D., Yilmaz, C., & Scholey, A. (2020) · Nutrients · doi:10.3390/nu12010228 · Cited by 541
Homocysteine, B Vitamins, and Cognitive Impairment
Smith, A. D., & Refsum, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050947 · Cited by 526
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
Reversal of cognitive decline: A novel therapeutic program
Bredesen, D. E. (2014) · Aging · doi:10.18632/aging.100690 · Cited by 231
Diet, cognition, and alzheimer’s disease: food for thought
Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martínez-Lage, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0561-3 · Cited by 214
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research
Guyonnet, S., Secher, M., & Vellas, B. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12058 · Cited by 186
Reversal of cognitive decline in Alzheimer's disease
Bredesen, D. E., Amos, E. C., Canick, J., Ackerley, M., Raji, C. A., Fiala, M., & Ahdidan, J. (2016) · Aging · doi:10.18632/aging.100981 · Cited by 186
Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans
Zetterberg, H., Mörtberg, E., Song, L., Chang, L., Provuncher, G. K., Patel, P. P., Ferrell, E. P., Fournier, D. R., Kan, C. W., Campbell, T. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028263 · Cited by 175
Folates and aging: Role in mild cognitive impairment, dementia and depression
Araújo, J. R., Martel, F., Borges, N., Araújo, J. M., & Keating, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.005 · Cited by 167
Homocysteine: a biomarker in neurodegenerative diseases
Herrmann, W., & Obeid, R. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.084 · Cited by 149
Wang, Z., Zhu, W. P., Xing, Y., Jia, J., & Tang, Y. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab057 · Cited by 147
Betaine attenuates Alzheimer‐like pathological changes and memory deficits induced by homocysteine
Chai, G., Jiang, X., Ni, Z.-F., Ma, Z., Xie, A., Cheng, X., Wang, Q., Wang, J., & Liu, G. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12094 · Cited by 145
Role of natural products for the treatment of Alzheimer’s disease
Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141
Figueroa‐Soto, C. G., & Valenzuela-Soto, E. M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.01.002 · Cited by 144
The Role of B Vitamins in Preventing and Treating Cognitive Impairment and Decline
Morris, M. S. (2012) · Advances in Nutrition · doi:10.3945/an.112.002535 · Cited by 145
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
Hooshmand, B., Polvikoski, T. M., Kivipelto, M., Tanskanen, M., Myllykangas, L., Erkinjuntti, T., Mäkelä, M., Oinas, M., Paetau, A. E., Scheltens, P., et al. (2013) · Brain · doi:10.1093/brain/awt206 · Cited by 130
Self-citationZamolodchikov, D., Renné, T., & Strickland, S. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13209 · Cited by 113
Vitamin B12status, cognitive decline and dementia: a systematic review of prospective cohort studies
O'Leary, F., Allman-Farinelli, M., & Samman, S. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004175 · Cited by 96
Hematologic manifestations ofHelicobacter pyloriinfection
Campuzano‐Maya, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12818 · Cited by 98
Hooshmand, B., Solomon, A., Kåreholt, I., Rusanen, M., Hänninen, T., Leiviskä, J., Winblad, B. G., Laatikainen, T. K., Soininen, H., & Kivipelto, M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02484.x · Cited by 95
Self-citationRomán, G. C., Páez, O. M., & Bernal, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020319 · Cited by 94
Hooshmand, B., Mangialasche, F., Kalpouzos, G., Solomon, A., Kåreholt, I., Smith, A. D., Refsum, H., Wang, R., Mühlmann, M., Ertl-Wagner, B. B., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0274 · Cited by 91
Self-citationDecreased vitamin B12 availability induces ER stress through impaired SIRT1-deacetylation of HSF1
Ghemrawi, R., Pooya, S., Lorentz, S., Gauchotte, G., Arnold, C., Guéant, J., & Battaglia-Hsu, S.-F. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.69 · Cited by 86
Folate and Alzheimer: when time matters
Hinterberger, M., & Fischer, P. A. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0822-y · Cited by 85
Chen, Z., Revenko, A. S., Singh, P. K., MacLeod, A. R., Norris, E. H., & Strickland, S. (2017) · Blood · doi:10.1182/blood-2016-11-753202 · Cited by 87
Vitamin B12 in neurology and ageing; Clinical and genetic aspects
McCaddon, A. (2012) · Biochimie · doi:10.1016/j.biochi.2012.11.017 · Cited by 90
Subclinical cobalamin deficiency
Carmel, R. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283505852 · Cited by 74
Understanding the cause of sporadic Alzheimer’s disease
Zetterberg, H., & Mattsson, N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915740 · Cited by 73
Sun, J., Wen, S., Zhou, J., & Ding, S. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22090 · Cited by 71
Akter, S., Hassan, M. R., Shahriar, M., Akter, N., Abbas, M. G., & Bhuiyan, M. A. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0164-8 · Cited by 72
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
Wang, Q., Zhao, J., Chang, H., Liu, X., & Zhu, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.665114 · Cited by 67
Vitamin B12 Intake and Status and Cognitive Function in Elderly People
Doets, E. L., van Wijngaarden, J. P., Szczecińska, A., Dullemeijer, C., Souverein, O. W., Dhonukshe-Rutten, R. A. M., Cavelaars, A. E. J. M., van 't Veer, P., Brzozowska, A., & de Groot, L. C. P. G. M. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs003 · Cited by 67
Zhou, F., & Chen, S. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.02.006 · Cited by 66
Non-polyphenolic natural inhibitors of amyloid aggregation
Ma, L., Yang, C., Zheng, J., Chen, Y., Xiao, Y., & Huang, K. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112197 · Cited by 66
Miwa, K., Tanaka, M. R., Okazaki, S., Yagita, Y., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150458 · Cited by 68
The Relationship Between Hyperhomocysteinemia and Neurodegeneration
Bonetti, F., Brombo, G., & Zuliani, G. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2015-0008 · Cited by 58
Sacuiu, S. F. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00008-2 · Cited by 57
Betaine—The dark knight of the brain
Bhatt, M., Iacovo, A. D., Romanazzi, T., Roseti, C., & Bossi, E. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13839 · Cited by 45
Koohpeyma, H., Goudarzi, I., Salmani, M. E., Lashkarbolouki, T., & Shabani, M. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00119-6 · Cited by 44
McCarty, M. F., O’Keefe, J. H., & DiNicolantonio, J. J. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109356 · Cited by 42
Neuro-nutrients as anti-alzheimer's disease agents: A critical review
Ravi, S. K., Narasingappa, R. B., & Vincent, B. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1481012 · Cited by 41
Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases
Orywal, K., Socha, K., Iwaniuk, P., Kaczyński, P., Farhan, J. A., Zoń, W., Łozowicka, B., Perkowski, M., & Mroczko, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031333 · Cited by 44
Jadavji, N. M., Farr, T. D., Lips, J., Khalil, A. A., Boehm‐Sturm, P., Foddis, M., Harms, C., Füchtemeier, M., & Dirnagl, U. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.040 · Cited by 36
Liang, S., Zhou, Y., Wang, H., Qian, Y., Ma, D., Tian, W., Persaud-Sharma, V., Yu, C., Ren, Y., Zhou, S.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/560183 · Cited by 35
Algorithm for the early diagnosis of vitamin B12 deficiency in elderly people.
Palacios, G., Sola, R., Barrios, L., Pietrzik, K. F., Castillo, M. J., & González‐Gross, M. (2013) · PubMed · doi:10.3305/nh.2013.28.5.6821 · Cited by 35
Obeid, R., Hartmuth, K., Herrmann, W., Gortner, L., Rohrer, T. R., Geisel, J., Reed, M. C., & Nijhout, H. F. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200162 · Cited by 35
Riedel, B. C., Daianu, M., Steeg, G. V., Mezher, A. F., Salminen, L. E., Galstyan, A., Thompson, P. M., & Initiative, A. D. N. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00390 · Cited by 32
Zuin, M., Cervellati, C., Brombo, G., Trentini, A., Roncon, L., & Zuliani, G. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.7 · Cited by 32
Association of Cognitive Impairment with Combinations of Vitamin B12–Related Parameters
Lildballe, D. L., Fedosov, S. N., Sherliker, P., Hin, H., Clarke, R., & Nexø, E. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165944 · Cited by 32
Risk Profiles of Alzheimer Disease
Bilbul, M., & Schipper, H. M. (2011) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012129 · Cited by 34
Polidori, M. C., & Pientka, L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111034 · Cited by 32
Serum homocysteine and risk of dementia in Japan
Chen, S., Honda, T., Ohara, T., Hata, J., Hirakawa, Y., Yoshida, D., Shibata, M., Sakata, S., Oishi, E., Furuta, Y., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322366 · Cited by 31
Folate/Vitamin B Alleviates Hyperhomocysteinemia-Induced Alzheimer-Like Pathologies in Rat Retina
Guo, J., Ni, S.-Z., Li, Q., Wang, J., & Yang, Y. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0293-8 · Cited by 31
Stunff, H. L., Véret, J., Kassis, N., Denom, J., Meneyrol, K., Paul, J., Cruciani‐Guglielmacci, C., Magnan, C., & Janel, N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00807 · Cited by 31
Gailer, J. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.12.001 · Cited by 29
Zajac, I. T., Herreen, D., Bastiaans, K., Dhillon, V. S., & Fenech, M. F. (2018) · Nutrients · doi:10.3390/nu11010019 · Cited by 27
Ligustrazine Attenuates Hyperhomocysteinemia-induced Alzheimer-like Pathologies in Rats
Zhang, Q., Wang, J., Zhu, L., Jiang, S., Liu, J., Wang, L., & Qin, X. (2021) · Current Medical Science · doi:10.1007/s11596-021-2379-1 · Cited by 27
Plasma homocysteine and cognitive decline in older hypertensive subjects
Narayan, S. K., Saxby, B. K., Firbank, M., O'Brien, J. T., Harrington, F., McKeith, I. G., Hansrani, M., Stansby, G. P., & Ford, G. A. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000779 · Cited by 28
Hyperhomocysteinemia and Disease—Is 10 μmol/L a Suitable New Threshold Limit?
Marroncini, G., Martinelli, S., Menchetti, S., Bombardiere, F., & Martelli, F. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212295 · Cited by 31
Moustafa, A. A., Hewedi, D. H., Eissa, A. M., Myers, C. E., & Sadek, H. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046496 · Cited by 26
Hyperhomocysteinemia Is a Risk Factor for Alzheimer's Disease in an Algerian Population
Nazef, K., Khelil, M., Chelouti, H., Kacimi, G., Bendini, M., Tazir, M., Belarbi, S., Cherifi, M. E. H., & Djerdjouri, B. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.03.001 · Cited by 25
MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer’s Disease?
Román, G. C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150304 · Cited by 24
Betaine suppressed Aβ generation by altering amyloid precursor protein processing
Liu, X., Qian, X., Xie, Y., Qi, Y., Peng, M.-F., Zhan, B.-C., & Lou, Z. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1630-y · Cited by 23
Tang, X., Chen, R., Dong, L., Ren, Y., Soldato, P. D., Sparatore, A., & Liao, D. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9862-x · Cited by 21
Semmler, A., Moskau‐Hartmann, S., Stoffel‐Wagner, B., Elger, C. E., & Linnebank, M. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0580 · Cited by 20
Zhang, L., Xie, X., Sun, Y., & Zhou, F. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s383654 · Cited by 19
Beaudry‐Richard, A., Abdelhak, A., Saloner, R., Sacco, S., Montes, S. C., Oertel, F. C., Cordano, C., Jabassini, N., Ananth, K., Gomez, A., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27200 · Cited by 19
An appraisal of folates as key factors in cognition and ageing-related diseases
Craenen, K., Verslegers, M., Baatout, S., & Benotmane, M. A. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1549017 · Cited by 18
Cajavilca, C. E., Gadhia, R. R., & Román, G. C. (2019) · Brain Sciences · doi:10.3390/brainsci9090211 · Cited by 17
Kocatürk, R. R., Temizyürek, A., Özcan, Ö. Ö., Erguzel, T. T., Karahan, M., Konuk, M., & Tarhan, N. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2079506 · Cited by 17
Epigenetics in Alzheimer’s Disease: A Critical Overview
Villa, C., & Combi, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115970 · Cited by 18
Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms.
Kitzlerová, E., Fišar, Z., Jirák, R., Zvěřová, M., Hroudová, J., Benaková, H., & Raboch, J. (2014) · PubMed · Cited by 17
Li, W., Yuan, W., Zhang, D., Cai, S., Luo, J., & Zeng, K. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00414-1 · Cited by 16
Genome‐wide meta‐analysis identifies ancestry‐specific loci for Alzheimer's disease
Ge, Y., Chen, S., Wu, B., Zhang, Y.-R., Wang, J., He, X., Liu, W., Chen, Y., Ou, Y., Shen, X., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14121 · Cited by 15
Processes of plasma proteinN-homocysteinylation in multiple sclerosis
Jamróz-Wiśniewska, A., Bełtowski, J., Bartosik-Psujek, H., Wójcicka, G., & Rejdak, K. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1241782 · Cited by 16
Homocysteine: A modifiable culprit of cognitive impairment for us to conquer?
Ji, Y., Lyu, P., Jin, W., Li, X., Li, X., & Dong, Y. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.07.015 · Cited by 19
Circulating biomarkers that predict incident dementia
Weinstein, G., & Seshadri, S. S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt235 · Cited by 16
Unveiling the crucial role of betaine: modulation of GABA homeostasis via SLC6A1 transporter (GAT1)
Bhatt, M., Lazzarin, E., Alberto-Silva, A. S., Domingo, G., Zerlotti, R., Gradisch, R., Bazzone, A., Sitte, H. H., Stockner, T., & Bossi, E. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05309-w · Cited by 16
Qiu, C. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.146 · Cited by 14
Rogne, S., Vangberg, T. R., Eldevik, P., Wikran, G., Mathiesen, E. B., & Schirmer, H. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000350408 · Cited by 11
Tiwari, P., Gupta, A., Kaushik, M., Yadav, A., Anjali, A., Dwivedi, R., Mudgal, P., Kumar, Y., Tripathi, M., & Dada, R. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf410 · Cited by 11
Gordon, S., Hoey, L., McNulty, H., Keenan, J., Pangilinan, F., Brody, L. C., Ward, M. H., Strain, J. J., McAnena, L. B., McCann, A., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04276-8 · Cited by 11
Chen, B.-A., Lee, W., Chung, C., Peng, L., & Chen, L. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.83 · Cited by 10
Helicobacter pylori and Hematologic Diseases
Campuzano‐Maya, G. (2016) · InTech eBooks · doi:10.5772/62971 · Cited by 10
Pedrero‐Chamizo, R., Albers, U., Palacios, G., Pietrzik, K. F., Meléndez, A., & González‐Gross, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197303 · Cited by 16
Basak, T., Garg, G., Bhardwaj, N., Tanwar, V. S., Seth, S., Karthikeyan, G., & Sengupta, S. (2016) · Biomarkers · doi:10.3109/1354750x.2016.1153718 · Cited by 9
Jiang, B., Ding, C., Yao, G.-E., Yao, C., Zhang, Y., Ge, J., & Qiu, E. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0033 · Cited by 9
Bull, C. F., Christensen, H. M., & Fenech, M. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119367 · Cited by 9
How to face the aging world – lessons from dementia research
Mitrečić, D., Petrović, D. J., Stančin, P., Isaković, J., Zavan, B., Tricarico, G., Tiljak, M. K., & Luca, M. D. (2020) · Croatian Medical Journal · doi:10.3325/cmj.2020.61.139 · Cited by 8
Homocysteine Levels in Neurological Disorders
Moustafa, A. A., Hewedi, D. H., Eissa, A. M., Frydecka, D., & Misiak, B. (2015) · doi:10.1002/9781118840634.ch7 · Cited by 8
Prevention of Alzheimer’s Disease: Intervention Studies
Mangialasche, F., Xu, W., & Kivipelto, M. (2013) · InTech eBooks · doi:10.5772/55034 · Cited by 7
Self-citationLinking atherosclerosis to Alzheimer's disease: focus on biomarkers
Emanuele, E. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/411 · Cited by 7
Lin, L., & Du, H. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.05.058 · Cited by 6
Murphy, M. J., Brandie, F. M., Ebare, M., Harrison, M., Dow, E., Bartlett, W. A., & Craig, D. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211003605 · Cited by 6
Sławek, J. W., & Białecka, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00057-4 · Cited by 6
Association analyses of nutritional markers with Parkinson’s disease and Alzheimer’s disease
Xu, D., Shen, Y. L., Hu, M., Li, L., Fang, Y., He, J., Ma, L.-L., Xu, S., & Wang, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40191 · Cited by 5
Neuropsychological assessment after long-term omeprazole treatment
Haefliger, R., Dries, L. S., Perassolo, M. S., & Cardoso, C. D. O. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2106570 · Cited by 3
Seshadri, S. S. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f8836f · Cited by 3
Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation
Miteva, M. T., Laurenti, D., Mattioli, R., Risola, D. D., Mariano, A., & Mosca, L. N. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1676497 · Cited by 2
Li, C., & Zhang, B. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00551-1 · Cited by 2
Metadata
- Authors
- Hooshmand, B., Solomon, A., Kåreholt, I., Leiviskä, J., Rusanen, M., Ahtiluoto, S., Winblad, B., Laatikainen, T., Soininen, H., & Kivipelto, M.
- Affiliations
- University of Eastern Finland (FI)
- Venue
- Neurology
- Published
- 2010-10-19
- Volume
- 75
- Issue
- 16
- Pages
- 1408-1414
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1979444541
- Cited by
- 122
- References
- 43
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 5 · 2019: 10 · 2018: 8 · 2017: 5 · 2016: 10 · 2015: 10 · 2014: 10 · 2013: 11 · 2012: 13
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- homocysteine, holotranscobalamin, Alzheimer's disease, fenfluramine, glucose tolerance, insulin, peripheral arterial disease, fasting lipids, cholesterol, low-density lipoprotein, free fatty acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review